Omnicell (NASDAQ: OMCL)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.850 | 0.840 | -0.0100 | ||||
REV | 339.450M | 331.386M | -8.064M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Omnicell (NASDAQ: OMCL) through any online brokerage.
Other companies in Omnicell’s space includes: Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG), Inari Medical (NASDAQ:NARI) and Smith & Nephew (NYSE:SNN).
The latest price target for Omnicell (NASDAQ: OMCL) was reported by Piper Sandler on Monday, August 8, 2022. The analyst firm set a price target for 150.00 expecting OMCL to rise to within 12 months (a possible 37.39% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Omnicell (NASDAQ: OMCL) is $109.18 last updated August 11, 2022, 8:00 PM UTC.
There are no upcoming dividends for Omnicell.
Omnicell’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Omnicell.
Omnicell is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.